ctrl K

Price Alert

Benitec Biopharma Inc. (BNTC)

NASDAQ: BNTC · Real-Time Price · USD

12.77

-0.24 (-1.84%)

At close: Aug 18, 2025, 3:59 PM

12.67

-0.78%

Pre-market: Aug 19, 2025, 08:00 AM EDT

Benitec Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	50.87M	2.48M	4.06M	19.77M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	87K	122K	160K	194K
Receivables	229K	55K	3K	25K
Inventory	n/a	13K	1.80	n/a
Other Current Assets	579K	1.2M	14K	15K
Total Current Assets	51.67M	3.73M	4.82M	20.61M
Property-Plant & Equipment	449K	613K	993K	577K
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	536K	735K	1.15M	771K
Total Assets	52.21M	4.46M	5.97M	21.38M
Account Payables	1.35M	1.14M	422K	274K
Deferred Revenue	n/a	-1.14M	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a
Other Current Liabilities	2.68M	472K	400K	276K
Total Current Liabilities	4.92M	3.98M	2.53M	1.37M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	38K	n/a	n/a	n/a
Total Long-Term Liabilities	38K	284K	559K	n/a
Total Liabilities	4.96M	4.26M	3.09M	1.37M
Total Debt	284K	559K	811K	213K
Common Stock	1K	n/a	1K	1K
Retained Earnings	-190.26M	-167.89M	-148.33M	-130.12M
Comprehensive Income	-892K	-830K	-1.25M	-1.46M
Shareholders Equity	47.25M	202K	2.88M	20.01M
Total Investments	n/a	n/a	n/a	n/a